Cognyte Software Ltd. closed its most recent fiscal year on January 31, 2026 with a sharp swing from operating loss to operating profit. The Israeli investigative-analytics specialist, spun out of Verint Systems in early 2021 and listed on Nasdaq under CGNT, has now produced two consecutive years of double-digit organic growth while expanding software gross margin by roughly one percentage point. The combination of a re-accelerating top line, a return to GAAP profitability, and a fresh capital return program signals that the post-spin reset phase is finally maturing into a stable operating posture. The execution has, however, been carried out under the shadow of geopolitical and human-rights scrutiny that distinguishes the issuer from adjacent enterprise-software comparables.
The economic substrate under that growth remains heavily concentrated by end customer and by geography. Israel alone contributed seventy percent of fiscal 2026 revenue, and two unnamed end customers jointly represented approximately thirty percent of consolidated sales. Remaining performance obligations of $557M provide a 1.4x forward revenue cover, but contract lengths skew toward a single year and discretionary government procurement cycles have historically produced material quarterly volatility. A recent regulatory furnishing announced the second-quarter earnings call without providing fresh operating data, and the next twelve months concentrate three live catalysts: the upcoming quarterly print, any incremental disclosure on the repurchase authorization that remains partially deployed, and the timing of any follow-on contract awards from anchor customers in EMEA.
The setup heading into the second-quarter print is therefore asymmetric in both directions. On the constructive side, the trailing-twelve-month revenue base has expanded to roughly $410M, balance sheet liquidity exceeds $109M against modest debt, and the multi-year runway stretches comfortably past the current operating plan. On the cautious side, customer concentration in a small number of Israeli and EMEA government agencies, the ever-present export-control overlay, and a fifty-two-week share-price drawdown leave the equity priced for execution rather than for option value. The coming year is best framed as a sequence of binary readouts rather than a smooth glide path.